|  |  |  | CVD Events | VTE events | ||
---|---|---|---|---|---|---|---|
 |  | All study participants | No CVD-related events | Composite CVD events†| CVD-related hospitalization | CVD-related death | VTE hospitalizations and death |
 |  | n | n (%) | n (%) | n (%) | n (%) | N (%) |
Demographic & clinical characteristics | 2,960 | 2,851 (96Â %) | 109 (4Â %) | 89 (3Â %) | 33 (1Â %) | 30 (1Â %) | |
Median Age at study start (IQR) | 37 (30, 43) | 36 (30, 43) | 42 (35, 51)* | 40 (35, 50)* | 46 (37, 58)* | 36.5 (31, 44) | |
Age | <30Â years | 710 (24Â %) | 692 (24Â %) | 18 (17Â %) | 14 (16Â %) | 5 (15Â %) | 7 (23Â %) |
 | 30–39 years | 1,107 (37 %) | 1,080 (38 %) | 27 (25 %) | 25 (28 %) | 6 (18 %)** | 11 (37 %) |
 | ≥40 years | 1,143 (39 %) | 1,079 (25 %) | 64 (59 %) | 50 (56 %) | 22 (67 %) | 12 (40 %) |
Male Gender | 1,924 (65Â %) | 1,849 (65Â %) | 75 (69Â %) | 64 (72Â %) | 21 (64Â %) | 23 (77Â %) | |
White Race | 1,605 (54Â %) | 1,554 (55Â %) | 51 (47Â %) | 40 (45Â %) | 15 (45Â %) | 12 (40Â %) | |
≤8 years of Education | 1,556 (53 %) | 1,487 (52 %) | 69 (64 %)** | 57 (64 %)** | 24 (73 %)** | 16 (53 %) | |
History of IDU | 61 (2Â %) | 58 (2Â %) | 3 (3Â %) | 3 (3Â %) | 1 (3Â %) | 0 (0Â %) | |
History of Cocaine Use | 262 (9Â %) | 255 (9Â %) | 7 (6Â %) | 6 (7Â %) | 1 (3Â %) | 2 (7Â %) | |
Time since HIV diagnosis, Median years (IQR) | 1.12 (0.13, 5.78) | 1.08 (0.13, 5.7) | 3.06 (0.24, 6.72)* | 3.06 (0.29, 6.5)* | 4.7 (0.24, 7.56) | 1.35 (0.13, 3.22) | |
% of time on ART since HIV diagnosis | 0.77 (0.47, 0.93) | 0.77 (0.47, 0.93) | 0.72 (0.43, 0.89) | 0.71 (0.42, 0.89) | 0.87 (0.52, 0.98) | 0.67 (0.41, 0.93) | |
Median Nadir CD4+ T-cell count, cells/mm3 (IQR) | 149 (52, 258) | 152 (53, 259) | 97 (27, 189)* | 88.5 (23, 203)* | 104.5 (23.5, 188.5)* | 91 (27.5, 182.5)* | |
Nadir CD4+ T-cell count ≤ 50 cecells/mm3 | 705 (24 %) | 666 (23 %) | 39 (36 %)** | 33 (37 %)** | 13 (39 %)** | 11 (37 %) | |
Virally suppressed year before event | 1,771 (60Â %) | 1,734 (61Â %) | 37 (34Â %)** | 29 (33Â %)** | 14 (42Â %)** | 9 (30Â %)** | |
Median viremia copy-years, log10 copy x years/mL (IQR) | 4.72 (3.99, 5.34) | 4.71 (3.98, 5.34) | 4.94 (4.33, 5.67) | 4.93 (4.28, 5.66)* | 4.43 (3.76, 5.06) | 5.08 (4.73, 5.82)* | |
Cardiovascular risk factors | |||||||
History of Diabetes Mellitus | 320 (11Â %) | 299 (10Â %) | 21 (19Â %)** | 18 (20Â %)** | 5 (15Â %) | 5 (17Â %) | |
History of Hypertension | 792 (27Â %) | 740 (26Â %) | 52 (48Â %)** | 42 (47Â %)** | 19 (58Â %)** | 9 (30Â %) | |
History of Dyslipidemiaa | 1,487 (50Â %) | 1,429 (50Â %) | 58 (53Â %) | 44 (49Â %) | 21 (64Â %) | 11 (37Â %) | |
History of Chronic kidney disease | 25 (<1Â %) | 23 (<1Â %) | 2 (2Â %) | 2 (2Â %) | 1 (3Â %) | 0 (0Â %) | |
>1 metabolic risk factors for CVD | 1,813 (61Â %) | 1,734 (61Â %) | 79 (72Â %)** | 62 (70Â %) | 29 (88Â %)** | 17 (57Â %) | |
Prior CVDb | 97 (3Â %) | 81 (3Â %) | 16 (15Â %)** | 9 (10Â %)** | 11 (33Â %)** | 2 (7Â %) | |
Ever smoked | 2,013 (68Â %) | 1,926 (68Â %) | 87 (80Â %)** | 67 (75Â %) | 33 (100Â %)** | 21 (70Â %) | |
Median weight kg (IQR)~ | 71.3 (62.5, 81.3) | 71.6 (62.8, 81.4) | 67.6 (60.5, 78.5) | 67.5 (60.1, 78.5) | 68.6 (60.3, 88) | 68.8 (61, 79.2) |